Medicure Ev To Sales vs Free Cash Flow Yield Analysis

MPH Stock

CAD 0.98 0.01 1.01%

Medicure financial indicator trend analysis is infinitely more than just investigating Medicure recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Medicure is a good investment. Please check the relationship between Medicure Ev To Sales and its Free Cash Flow Yield accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medicure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Ev To Sales vs Free Cash Flow Yield

Ev To Sales vs Free Cash Flow Yield Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Medicure Ev To Sales account and Free Cash Flow Yield. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Medicure's Ev To Sales and Free Cash Flow Yield is 0.95. Overlapping area represents the amount of variation of Ev To Sales that can explain the historical movement of Free Cash Flow Yield in the same time period over historical financial statements of Medicure, assuming nothing else is changed. The correlation between historical values of Medicure's Ev To Sales and Free Cash Flow Yield is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ev To Sales of Medicure are associated (or correlated) with its Free Cash Flow Yield. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow Yield has no effect on the direction of Ev To Sales i.e., Medicure's Ev To Sales and Free Cash Flow Yield go up and down completely randomly.

Correlation Coefficient

0.95

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Most indicators from Medicure's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Medicure current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medicure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Medicure's Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to climb to about 26.2 K in 2024, whereas Enterprise Value Over EBITDA is likely to drop 4.46 in 2024.

	2021	2022	2023	2024 (projected)
Total Revenue	21.7M	23.1M	21.7M	11.8M
Depreciation And Amortization	3.1M	2.1M	2.2M	1.2M

Total Revenue Depreciation And Amortization

Medicure fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Other Current Assets	Total Liab	Total Current Assets	Common Stock	Accounts Payable	Inventory	Other Stockholder Equity	Intangible Assets	Non Currrent Assets Other	Other Assets	Non Current Liabilities Total	Short Long Term Debt Total	Short Term Debt	Other Current Liab	Other Liab
Total Assets		0.97	0.72	0.78	0.54	0.18	0.6	0.84	0.4	0.55	0.59	0.89	0.9	0.77	0.36	0.89	0.83	-0.18	0.77	0.39	0.52	0.78	0.71	0.05	0.89	0.82
Total Current Liabilities	0.97		0.63	0.78	0.61	0.1	0.41	0.83	0.18	0.64	0.6	0.96	0.91	0.73	0.39	0.81	0.79	-0.2	0.77	0.5	0.44	0.78	0.7	0.05	0.95	0.82
Total Stockholder Equity	0.72	0.63		0.18	-0.18	0.49	0.75	0.25	0.7	0.7	0.52	0.66	0.34	0.96	0.24	0.78	0.44	-0.19	0.16	0.59	0.89	0.15	0.06	-0.33	0.54	0.22
Property Plant And Equipment Net	0.78	0.78	0.18		0.86	-0.02	0.31	0.99	0.04	0.05	0.3	0.6	0.94	0.21	0.16	0.66	0.89	-0.12	1.0	-0.11	-0.11	0.96	0.92	0.27	0.68	0.96
Net Debt	0.54	0.61	-0.18	0.86		-0.37	-0.13	0.86	-0.32	-0.01	0.2	0.5	0.85	-0.05	0.24	0.28	0.59	0.02	0.88	-0.09	-0.31	0.92	0.91	0.47	0.64	0.89
Retained Earnings	0.18	0.1	0.49	-0.02	-0.37		0.43	-0.04	0.32	0.23	-0.42	0.14	-0.08	0.35	-0.72	0.24	0.12	-0.2	-0.06	0.19	0.3	-0.17	-0.07	0.0	0.07	-0.12
Cash	0.6	0.41	0.75	0.31	-0.13	0.43		0.34	0.91	0.13	0.4	0.29	0.33	0.65	0.12	0.79	0.56	-0.17	0.28	-0.03	0.56	0.26	0.2	-0.18	0.22	0.31
Non Current Assets Total	0.84	0.83	0.25	0.99	0.86	-0.04	0.34		0.1	0.12	0.35	0.67	0.97	0.3	0.23	0.69	0.88	-0.11	0.99	-0.03	-0.01	0.98	0.93	0.28	0.74	0.98
Cash And Short Term Investments	0.4	0.18	0.7	0.04	-0.32	0.32	0.91	0.1		0.04	0.33	0.09	0.1	0.59	0.2	0.58	0.26	-0.11	0.02	-0.06	0.66	0.04	0.0	-0.19	0.02	0.08
Net Receivables	0.55	0.64	0.7	0.05	-0.01	0.23	0.13	0.12	0.04		0.5	0.82	0.3	0.82	0.3	0.4	0.17	-0.13	0.04	0.98	0.72	0.08	0.01	-0.2	0.72	0.14
Common Stock Shares Outstanding	0.59	0.6	0.52	0.3	0.2	-0.42	0.4	0.35	0.33	0.5		0.57	0.48	0.62	0.88	0.65	0.49	-0.12	0.29	0.39	0.51	0.37	0.16	-0.4	0.5	0.38
Other Current Assets	0.89	0.96	0.66	0.6	0.5	0.14	0.29	0.67	0.09	0.82	0.57		0.79	0.79	0.36	0.69	0.63	-0.16	0.6	0.71	0.55	0.63	0.56	0.03	0.98	0.68
Total Liab	0.9	0.91	0.34	0.94	0.85	-0.08	0.33	0.97	0.1	0.3	0.48	0.79		0.44	0.34	0.71	0.84	-0.12	0.94	0.16	0.14	0.97	0.92	0.29	0.86	0.98
Total Current Assets	0.77	0.73	0.96	0.21	-0.05	0.35	0.65	0.3	0.59	0.82	0.62	0.79	0.44		0.37	0.75	0.43	-0.19	0.2	0.71	0.91	0.23	0.15	-0.24	0.68	0.3
Common Stock	0.36	0.39	0.24	0.16	0.24	-0.72	0.12	0.23	0.2	0.3	0.88	0.36	0.34	0.37		0.34	0.2	0.07	0.18	0.26	0.37	0.29	0.1	-0.3	0.33	0.28
Accounts Payable	0.89	0.81	0.78	0.66	0.28	0.24	0.79	0.69	0.58	0.4	0.65	0.69	0.71	0.75	0.34		0.86	-0.28	0.64	0.21	0.5	0.59	0.47	-0.23	0.62	0.64
Inventory	0.83	0.79	0.44	0.89	0.59	0.12	0.56	0.88	0.26	0.17	0.49	0.63	0.84	0.43	0.2	0.86		-0.23	0.87	-0.02	0.09	0.8	0.71	-0.02	0.63	0.82
Other Stockholder Equity	-0.18	-0.2	-0.19	-0.12	0.02	-0.2	-0.17	-0.11	-0.11	-0.13	-0.12	-0.16	-0.12	-0.19	0.07	-0.28	-0.23		-0.1	-0.07	-0.1	-0.06	-0.04	-0.04	-0.13	-0.08
Intangible Assets	0.77	0.77	0.16	1.0	0.88	-0.06	0.28	0.99	0.02	0.04	0.29	0.6	0.94	0.2	0.18	0.64	0.87	-0.1		-0.11	-0.12	0.97	0.93	0.29	0.69	0.97
Non Currrent Assets Other	0.39	0.5	0.59	-0.11	-0.09	0.19	-0.03	-0.03	-0.06	0.98	0.39	0.71	0.16	0.71	0.26	0.21	-0.02	-0.07	-0.11		0.69	-0.05	-0.1	-0.18	0.62	0.0
Other Assets	0.52	0.44	0.89	-0.11	-0.31	0.3	0.56	-0.01	0.66	0.72	0.51	0.55	0.14	0.91	0.37	0.5	0.09	-0.1	-0.12	0.69		-0.05	-0.11	-0.25	0.44	0.01
Non Current Liabilities Total	0.78	0.78	0.15	0.96	0.92	-0.17	0.26	0.98	0.04	0.08	0.37	0.63	0.97	0.23	0.29	0.59	0.8	-0.06	0.97	-0.05	-0.05		0.97	0.39	0.74	1.0
Short Long Term Debt Total	0.71	0.7	0.06	0.92	0.91	-0.07	0.2	0.93	0.0	0.01	0.16	0.56	0.92	0.15	0.1	0.47	0.71	-0.04	0.93	-0.1	-0.11	0.97		0.55	0.7	0.97
Short Term Debt	0.05	0.05	-0.33	0.27	0.47	0.0	-0.18	0.28	-0.19	-0.2	-0.4	0.03	0.29	-0.24	-0.3	-0.23	-0.02	-0.04	0.29	-0.18	-0.25	0.39	0.55		0.18	0.37
Other Current Liab	0.89	0.95	0.54	0.68	0.64	0.07	0.22	0.74	0.02	0.72	0.5	0.98	0.86	0.68	0.33	0.62	0.63	-0.13	0.69	0.62	0.44	0.74	0.7	0.18		0.77
Other Liab	0.82	0.82	0.22	0.96	0.89	-0.12	0.31	0.98	0.08	0.14	0.38	0.68	0.98	0.3	0.28	0.64	0.82	-0.08	0.97	0.0	0.01	1.0	0.97	0.37	0.77

Click cells to compare fundamentals

Medicure Account Relationship Matchups

Medicure fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	42.3M	34.1M	28.4M	29.9M	28.1M	39.2M
Total Current Liabilities	11.7M	12.3M	8.5M	8.4M	7.9M	13.3M
Total Stockholder Equity	26.9M	19.1M	18.4M	21.0M	19.9M	15.4M
Property Plant And Equipment Net	1.3M	1.6M	1.6M	1.2M	736K	888.0K
Net Debt	(11.9M)	(1.3M)	(2.5M)	(4.0M)	(5.8M)	(5.5M)
Retained Earnings	(62.6M)	(65.6M)	(66.3M)	(64.9M)	(65.9M)	(69.1M)
Cash	13.0M	2.7M	3.7M	4.9M	6.4M	6.8M
Non Current Assets Total	10.9M	18.4M	15.9M	15.1M	12.9M	16.1M
Cash And Short Term Investments	13.0M	2.7M	3.7M	4.9M	6.4M	8.7M
Net Receivables	10.2M	5.3M	4.7M	5.6M	4.8M	7.7M
Common Stock Shares Outstanding	15.0M	10.7M	10.3M	10.4M	12.0M	10.8M
Liabilities And Stockholders Equity	42.3M	34.1M	28.4M	29.9M	28.1M	40.7M
Other Current Assets	1.9M	2.6M	872K	1.1M	1.1M	2.0M
Total Liab	15.3M	14.9M	10.0M	8.9M	8.2M	7.8M
Total Current Assets	31.4M	15.7M	12.6M	14.8M	15.2M	23.7M
Common Stock	125.7M	122.9M	85.4M	80.9M	81.0M	98.8M
Accounts Payable	9.4M	7.0M	6.7M	7.1M	7.2M	5.7M
Inventory	6.3M	5.1M	3.3M	3.2M	2.9M	2.4M
Other Stockholder Equity	10.0M	10.3M	10.4M	10.5M	10.7M	10.2M
Intangible Assets	9.6M	13.6M	11.2M	10.6M	8.9M	10.5M
Non Currrent Assets Other	39K	156K	57K	63K	75K	71.3K
Other Assets	12.2M	39K	156K	57K	65.6K	62.3K
Accumulated Other Comprehensive Income	(5.8M)	(6.5M)	(6.6M)	(5.5M)	(6.0M)	(5.7M)
Non Current Liabilities Total	3.7M	2.6M	1.5M	503K	229K	217.6K
Other Current Liab	872K	2.3M	716K	179K	382K	362.9K
Other Liab	3.2M	2.8M	1.5M	696K	626.4K	595.1K
Net Tangible Assets	81.9M	17.3M	2.6M	4.2M	4.9M	7.8M
Property Plant Equipment	316K	1.3M	1.6M	1.6M	1.9M	1.9M
Non Current Liabilities Other	3.2M	1.2M	386K	105K	94.5K	89.8K
Net Invested Capital	26.9M	19.1M	18.4M	21.0M	19.9M	30.8M
Net Working Capital	19.7M	3.4M	4.0M	6.5M	7.3M	6.9M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Medicure Stock Analysis

When running Medicure's price analysis, check to measure Medicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicure is operating at the current time. Most of Medicure's value examination focuses on studying past and present price action to predict the probability of Medicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicure's price. Additionally, you may evaluate how the addition of Medicure to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC